| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/17/2009 | US20090232769 Pharmaceutical Composition For Treatment Of Blood Clotting Disorder |
| 09/17/2009 | US20090232768 Novel compounds and methods for therapy |
| 09/17/2009 | US20090232767 Methods and compositions based on diphtheria toxin-interleukin-3 conjugates |
| 09/17/2009 | US20090232737 Purification of proteins |
| 09/17/2009 | DE102008014880A1 Use of a polypeptide with the activity of repulsive guidance molecule A as an antiinflammatory agent |
| 09/17/2009 | DE102008013490A1 Verfahren zur Reinigung therapeutischer Proteine Methods for cleaning up of therapeutic proteins |
| 09/17/2009 | CA2719102A1 A novel pharmaceutical preparation for preeclampsia, eclampsia, and toxemia and their related symptoms and related disorders of pregnancy |
| 09/17/2009 | CA2718495A1 Recombinant production of authentic human proteins using human cell expression systems |
| 09/17/2009 | CA2718395A1 Cyclic compound and salt thereof |
| 09/17/2009 | CA2718394A1 Microorganism producing cyclic compound |
| 09/17/2009 | CA2718237A1 Method of treatment using antimicrobial composition |
| 09/17/2009 | CA2718182A1 Treatment of pompe disease with specific pharmacological chaperones and monitoring treatment using surrogate markers |
| 09/17/2009 | CA2718153A1 Angiostatic compositions comprising truncated tyrosyl-trna synthetase polypeptides and methods of using same |
| 09/17/2009 | CA2717930A1 Novel gp96 derived peptides |
| 09/17/2009 | CA2717699A1 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 09/17/2009 | CA2717543A1 A method for the production of a human protein in a plant, in particular a human recombinant lysosomal enzyme in a cereal endosperm |
| 09/17/2009 | CA2717322A1 Apoaequorin-containing compositions and methods of using same |
| 09/16/2009 | EP2100968A1 Method of producing recombinant TAT-HOXB4H protein for use as a stimulant of hematopoiesis in vivo |
| 09/16/2009 | EP2100960A2 Specific polypeptides and nucleic acids of pathogenic strains of the Neisseria genus |
| 09/16/2009 | EP2100959A2 Mammalian cytokine: interleukin-B30 and related reagents |
| 09/16/2009 | EP2100901A1 Modified Insulin and conjugates thereof |
| 09/16/2009 | EP2100899A2 Compounds for proteasome enzyme inhibition |
| 09/16/2009 | EP2100898A1 A process for concentration of a polypeptide |
| 09/16/2009 | EP2100618A2 PDGFR-alpha antagonists for treatment of metastatic bone cancer |
| 09/16/2009 | EP2100614A2 PDGFR-alpha antagonists for treatment of metastatic bone cancer |
| 09/16/2009 | EP2099913A1 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions |
| 09/16/2009 | EP2099907A2 Lipase variants for pharmaceutical use |
| 09/16/2009 | EP2099906A1 Compositions of and methods of using sulfatases from flavobacterium heparinum |
| 09/16/2009 | EP2099821A2 Novel genes and proteins that home to developing microvessels |
| 09/16/2009 | EP2099815A2 Novel amides acting on the adenosine receptors |
| 09/16/2009 | EP2099488A1 Tslp vaccine for the treatment of th2 mediated inflammatory conditions |
| 09/16/2009 | EP2099481A1 Vaccin against group a beta hemolytic streptococcus and respective process for obtaining thereof |
| 09/16/2009 | EP2099477A2 Use of the endoglycosidase endos for treating immunoglobulin g mediated diseases |
| 09/16/2009 | EP2099476A1 Methods of treating alzheimer's disease |
| 09/16/2009 | EP2099475A1 Subcutaneous administration of coagulation factor viia-related popypeptdes |
| 09/16/2009 | EP2099474A1 Use of ghrelin to reverse hair loss |
| 09/16/2009 | EP2099473A2 Potentiation of erythropoietin (epo) action by membrane steroid receptor agonists |
| 09/16/2009 | EP2099472A2 Intra-vascular kidney gene therapy with plasmid encoding bmp-7 |
| 09/16/2009 | EP2099471A2 Uses of cerberus, coco and derivatives thereof |
| 09/16/2009 | EP2099470A1 Use of mage a3-protein d fusion antigen in immunotherapy combined with surgery, chemotherapy or radiotherapy for the treatment of cancer |
| 09/16/2009 | EP2099468A2 Methods of use of trk receptor modulators |
| 09/16/2009 | EP2099467A2 Atap peptides, nucleic acids encoding the same and associated methods of use |
| 09/16/2009 | EP2099466A1 Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears |
| 09/16/2009 | EP2099437A2 Porous keratin construct and method of making the same |
| 09/16/2009 | EP2099429A2 Micellar nanoparticles comprising botulinum toxin |
| 09/16/2009 | EP1994048B1 Pegylated mutated clostridium botulinum toxin |
| 09/16/2009 | EP1951276B1 Oligopeptides and their use |
| 09/16/2009 | EP1924593B1 Hcv ns3 protease inhibitors |
| 09/16/2009 | EP1893185B1 USE OF UROKINASE INHIBITORS FOR THE TREATMENT AND/OR PREVENTION OF AMYOTROPhIC LATERAL SCLEROSIS (ALS) |
| 09/16/2009 | EP1766024B1 Proteins with attached short peptide of acidic amino acids |
| 09/16/2009 | EP1661909B1 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 09/16/2009 | EP1625395B1 Method for identifying tff2 regulating agents |
| 09/16/2009 | EP1517919B9 Marked peptides having affinity for a phospholipid and uses |
| 09/16/2009 | EP1463836B1 Vector mediated organelle transfection |
| 09/16/2009 | EP1399479B1 Cation conducting gaba a receptors and their use |
| 09/16/2009 | EP1324776B1 Reduced-viscosity concentrated protein formulations |
| 09/16/2009 | EP1254238B1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 09/16/2009 | EP1223978B9 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 09/16/2009 | EP1126878B1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 09/16/2009 | EP1100815B1 Protease susceptibility ii |
| 09/16/2009 | EP1093462B1 Compound capable of inhibiting the binding of a protein to mast cells, use of the compound for the preparation of a drug, a pharmaceutical composition, a method of diagnosing a disease, and a method of selection |
| 09/16/2009 | EP1027443B1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 09/16/2009 | EP1002084B1 Mammalian cytokine: interleukin-b30 and related reagents |
| 09/16/2009 | CN101535333A Process for controlling protein to salt ratio in animal muscle protein composition and protein composition reference to related application |
| 09/16/2009 | CN101534853A Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases |
| 09/16/2009 | CN101534852A Sensitization of tumor cells to radiation therapy through the administration of endothelin agonists |
| 09/16/2009 | CN101534851A Methods and compositions for promoting organ development |
| 09/16/2009 | CN101534850A Vitreous administration of erythropoietin |
| 09/16/2009 | CN101534849A Inhibition of placenta growth factor (plgf) medicated metastasis and/or angiogenesis |
| 09/16/2009 | CN101534848A Antiviral agent against animal viruses |
| 09/16/2009 | CN101534847A Modified erythropoietin |
| 09/16/2009 | CN101534846A Glucagon analogs exhibiting physiological solubility and stability |
| 09/16/2009 | CN101532019A Core fragment of human ZHX2 transcription factor and application thereof |
| 09/16/2009 | CN101531715A Cytokine protein family |
| 09/16/2009 | CN101531707A New antitumoral compounds |
| 09/16/2009 | CN101531706A Tumor vascular targeting peptide GX1 |
| 09/16/2009 | CN101531704A Peptide-based compounds |
| 09/16/2009 | CN101531703A Beta lamellar blocking peptide for preventing and/or curing Alzheimer's disease |
| 09/16/2009 | CN101530621A Oxidation resisting dipeptide medicament intercalated houghite and preparation method thereof |
| 09/16/2009 | CN101530611A The new function of I-kallikrein in preparing the medicine for curing secondary damage of brain damage after remote part |
| 09/16/2009 | CN101530610A Composition for cleaning liver and gall toxin |
| 09/16/2009 | CN101530609A Nanometer Shuxuetong injection preparation and preparation method thereof |
| 09/16/2009 | CN101530608A Composition with functions of resisting radiation and improving skin moisture |
| 09/16/2009 | CN101530430A Nanometer earthworm oral preparation and preparation method thereof |
| 09/16/2009 | CN100540666C Method for producing human insulin by transgenic romaine lettuce, tomato and tobacco |
| 09/16/2009 | CN100540566C Analogues of GLP-1 |
| 09/16/2009 | CN100540526C Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 09/16/2009 | CN100540058C Use of IL-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases |
| 09/16/2009 | CN100540055C Biodegradable block copolymeric compositions for drug delivery |
| 09/16/2009 | CN100540049C Fibronectin active tears and production method thereof |
| 09/16/2009 | CN100540048C Angiogenesis inducer |
| 09/16/2009 | CN100540047C Application of TRAP protein in preparing medicine for treating infection of staphylococcus aureus |
| 09/15/2009 | US7590494 leukotriene A4 (LTA4) hydrolase; identifying enzyme inhibitors, as antiinflammatory agents |
| 09/15/2009 | US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia |
| 09/15/2009 | US7589189 By using a double-stranded RNA (dsRNA); neurodegenerative disorder |
| 09/15/2009 | US7589185 Nucleotide sequences and protein(s) encoded by such nucleotides for modulation of apoptosis |
| 09/15/2009 | US7589178 Fusion polypeptide comprising fibrinopeptide A, serine protease and thrombin-cleavable sequences for use in identifying modulators for prevention and treatment of thrombotic disorders; anticoagulants |
| 09/15/2009 | US7589172 PRO256 polypeptides |
| 09/15/2009 | US7589171 Polyamides for treating human papilloma virus |
| 09/15/2009 | US7589170 Synthesis of cyclic peptides |